search
Company Information
USD
18.53
- (1.3%)
NASDAQ:TYRA, TYRA BIOSCIENCES, INC.
Industry: Biotechnology
End of Day: 2 May 2024 GMT-4
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its lead product candidate is TYRA-300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Address

2656 State Street

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Ali D. Fawaz
General Counsel/Secretary
Dr. Gilla Kaplan,PhD
Director
Mr. Robert J. More
Chairman of the Board/Director
Mr. Alan Fuhrman
CFO/Chief Accounting Officer
Ms. Nina Kjellson
Director
Mr. Isan Chen
Director/Other Corporate Officer
Dr. Todd Harris, PhD
CEO/Director/President
Dr. Jake Simson, PhD
Director
Mr. Rehan Verjee
Director
Dr. Melissa McCracken, PhD
Director
Dr. Siddarth Subramony, PhD
Director
Mr. Daniel Bensen
COO
Dr. Ronald V. Swanson, PhD
Chief Scientific Officer
Dr. Hiroomi Tada, M.D.,PhD
Chief Medical Officer
Dr. Robert L. Hudkins, PhD
Chief Technology Officer
Dr. Piyush Patel, PhD
Other Executive Officer

Ownership

Institution Holdings

RA Capital Management, LP
10,448,907 (19.962%)
RA Capital Management, LLC
7,236,454 (13.825%)
Boxer Capital LLC
6,448,359 (12.319%)
Canaan Partners XI LLC
4,409,991 (8.425%)
FMR LLC
3,879,123 (7.411%)
FMR Inc
2,768,696 (5.289%)
Fidelity Management & Research Company LLC
2,748,089 (5.250%)
Bvf Inc
2,739,595 (5.234%)
Nextech Invest AG
2,518,582 (4.812%)
TCG Crossover Management, LLC
1,989,103 (3.800%)

Individual Holdings

Dr. Todd Harris, PhD
1,502,697 (3.490%)
Mr. Daniel Bensen
433,684 (0.829%)
Mr. Isan Chen
192,783 (0.453%)
Dr. Hiroomi Tada, M.D.,PhD
84,467 (0.196%)
Dr. Gilla Kaplan,PhD
28,231 (0.077%)
Mr. Alan Fuhrman
1,463 (0.003%)

Funds Holdings

Fidelity Series Small Cap Opps Fd
826,607 (1.579%)
iShares Russell 2000 ETF
333,429 (0.637%)
JPMorgan US Small Company Fund
149,834 (0.286%)
Fidelity Small Cap Index Fund
139,326 (0.266%)
iShares Russell 2000 Value ETF
83,472 (0.159%)
State Street Russell Small/Mid Cap®
81,788 (0.156%)
State Street Russell Small Cap® Index
47,085 (0.090%)
Vanguard Russell 2000 Index Fund
46,617 (0.089%)
iShares Russell 2000 Growth ETF
43,682 (0.083%)
NT R2000 Index Fund - NL
41,772 (0.080%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices